7 research outputs found
Indications for breast magnetic resonance imaging. Consensus document "Attualità in senologia", Florence 2007.
Indications for breast magnetic resonance imaging. Consensus Document “Attualità in Senologia, Florence 2007. Indicazioni alla risonanza magnetica mammaria. Documento di Consenso “Attualità in senologia"
Indications for breast magnetic resonance imaging. Consensus document “Attualità in Senologia”, Florence 2007
The clinical use of breast magnetic resonance (MR) imaging is increasing, especially for applications requiring paramagnetic contrast-agent injection. This document presents a synthetic list of acceptable indications with potential advantages for women according to evidence from the literature and the expert opinion of the panel that developed this statement. We generally recommend that breast MR imaging be performed in centres with experience in conventional breast imaging [mammography and ultrasonography (US)] and needle-biopsy procedures (under stereotactic or US guidance) as well as in breast MR imaging and second-look US for findings not revealed by conventional imaging performed before MR imaging. In our opinion, there is no evidence in favour of breast MR imaging as a diagnostic tool to characterise equivocal findings at conventional imaging when needle-biopsy procedures can be performed, nor for the study of asymptomatic, non-high-risk women with negative conventional imaging. After a description of technical and methodological requirements, we define the indications and limitations of breast MR imaging for surveillance of high-risk women, local staging before surgery, evaluation of the effect of neoadjuvant chemotherapy, breast previously treated for carcinoma, carcinoma of unknown primary syndrome, nipple discharge and breast implants
Indications for breast magnetic resonance imaging. Consensus Document "Attualit\ue0 in Senologia", Florence 2007
The clinical use of breast magnetic resonance (MR) imaging is increasing, especially for applications requiring paramagnetic contrast-agent injection. This document presents a synthetic list of acceptable indications with potential advantages for women according to evidence from the literature and the expert opinion of the panel that developed this statement. We generally recommend that breast MR imaging be performed in centres with experience in conventional breast imaging [mammography and ultrasonography (US)] and needle-biopsy procedures (under stereotactic or US guidance) as well as in breast MR imaging and second-look US for findings not revealed by conventional imaging performed before MR imaging. In our opinion, there is no evidence in favour of breast MR imaging as a diagnostic tool to characterise equivocal findings at conventional imaging when needle-biopsy procedures can be performed, nor for the study of asymptomatic, non-high-risk women with negative conventional imaging. After a description of technical and methodological requirements, we define the indications and limitations of breast MR imaging for surveillance of high-risk women, local staging before surgery, evaluation of the effect of neoadjuvant chemotherapy, breast previously treated for carcinoma, carcinoma of unknown primary syndrome, nipple discharge and breast implants
Indications for breast magnetic resonance imaging. Consensus document "Attualita' in senologia", Florence 2007.
The clinical use of breast magnetic resonance (MR)
imaging is increasing, especially for applications requiring
paramagnetic contrast-agent injection. This document
presents a synthetic list of acceptable indications with
potential advantages for women according to evidence
from the literature and the expert opinion of the panel that
developed this statement. We generally recommend that
breast MR imaging be performed in centres with
experience in conventional breast imaging [mammography
and ultrasonography (US)] and needle-biopsy procedures
(under stereotactic or US guidance) as well as in breast
MR imaging and second-look US for findings not revealed
by conventional imaging performed before MR imaging.
In our opinion, there is no evidence in favour of breast MR
imaging as a diagnostic tool to characterise equivocal
findings at conventional imaging when needle-biopsy
procedures can be performed, nor for the study of
asymptomatic, non-high-risk women with negative
conventional imaging. After a description of technical and
methodological requirements, we define the indications
and limitations of breast MR imaging for surveillance of
high-risk women, local staging before surgery, evaluation
of the effect of neoadjuvant chemotherapy, breast
previously treated for carcinoma, carcinoma of unknown
primary syndrome, nipple discharge and breast implants